469 related articles for article (PubMed ID: 2550833)
1. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
Ratka A; Sutanto W; Bloemers M; de Kloet ER
Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
[TBL] [Abstract][Full Text] [Related]
2. Evidence for mineralocorticoid receptor facilitation of glucocorticoid receptor-dependent regulation of hypothalamic-pituitary-adrenal axis activity.
Spencer RL; Kim PJ; Kalman BA; Cole MA
Endocrinology; 1998 Jun; 139(6):2718-26. PubMed ID: 9607777
[TBL] [Abstract][Full Text] [Related]
3. Differential central effects of mineralocorticoid and glucocorticoid agonists and antagonists on blood pressure.
van den Berg DT; de Kloet ER; van Dijken HH; de Jong W
Endocrinology; 1990 Jan; 126(1):118-24. PubMed ID: 2293978
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytic-like effects of selective mineralocorticoid and glucocorticoid antagonists on fear-enhanced behavior in the elevated plus-maze.
Korte SM; de Boer SF; de Kloet ER; Bohus B
Psychoneuroendocrinology; 1995; 20(4):385-94. PubMed ID: 8532822
[TBL] [Abstract][Full Text] [Related]
5. Selective blockade of the mineralocorticoid receptor impairs hypothalamic-pituitary-adrenal axis expression of habituation.
Cole MA; Kalman BA; Pace TW; Topczewski F; Lowrey MJ; Spencer RL
J Neuroendocrinol; 2000 Oct; 12(10):1034-42. PubMed ID: 11012846
[TBL] [Abstract][Full Text] [Related]
6. Blockage of glucocorticoid, but not mineralocorticoid receptors prevents the persistent increase in circulating basal corticosterone concentrations following stress in the rat.
Moldow RL; Beck KD; Weaver S; Servatius RJ
Neurosci Lett; 2005 Feb; 374(1):25-8. PubMed ID: 15631890
[TBL] [Abstract][Full Text] [Related]
7. Glucocorticoid and mineralocorticoid receptors are involved in the facilitation of anxiety-like response induced by restraint.
Calvo N; Volosin M
Neuroendocrinology; 2001 Apr; 73(4):261-71. PubMed ID: 11340340
[TBL] [Abstract][Full Text] [Related]
8. Antiglucocorticoid RU 38486 attenuates retention of a behaviour and disinhibits the hypothalamic-pituitary adrenal axis at different brain sites.
De Kloet ER; De Kock S; Schild V; Veldhuis HD
Neuroendocrinology; 1988 Feb; 47(2):109-15. PubMed ID: 3344063
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of RU28318 and RU40555 as selective mineralocorticoid receptor and glucocorticoid receptor antagonists, respectively: receptor measures and functional studies.
Kim PJ; Cole MA; Kalman BA; Spencer RL
J Steroid Biochem Mol Biol; 1998 Nov; 67(3):213-22. PubMed ID: 9879980
[TBL] [Abstract][Full Text] [Related]
10. Repeated blockade of mineralocorticoid receptors, but not of glucocorticoid receptors impairs food rewarded spatial learning.
Douma BR; Korte SM; Buwalda B; la Fleur SE; Bohus B; Luiten PG
Psychoneuroendocrinology; 1998 Jan; 23(1):33-44. PubMed ID: 9618750
[TBL] [Abstract][Full Text] [Related]
11. Facilitation of feedback inhibition through blockade of glucocorticoid receptors in the hippocampus.
van Haarst AD; Oitzl MS; de Kloet ER
Neurochem Res; 1997 Nov; 22(11):1323-8. PubMed ID: 9355104
[TBL] [Abstract][Full Text] [Related]
12. Disruption of mineralocorticoid receptor function increases corticosterone responding to a mild, but not moderate, psychological stressor.
Pace TW; Spencer RL
Am J Physiol Endocrinol Metab; 2005 Jun; 288(6):E1082-8. PubMed ID: 15671079
[TBL] [Abstract][Full Text] [Related]
13. Further studies in deoxycorticosterone acetate treated rats: brain content of mineralocorticoid and glucocorticoid receptors and effect of steroid antagonists on salt intake.
Vallee SM; Grillo CA; Gonzalez S; Cosen-Binker L; de Kloet ER; McEwen BS; De Nicola AF
Neuroendocrinology; 1995 Feb; 61(2):117-24. PubMed ID: 7753331
[TBL] [Abstract][Full Text] [Related]
14. Opposing roles of glucocorticoid receptor and mineralocorticoid receptor in trimethyltin-induced cytotoxicity in the mouse hippocampus.
Ogita K; Sugiyama C; Acosta GB; Kuramoto N; Shuto M; Yoneyama M; Nakamura Y; Shiba T; Yamaguchi T
Neurosci Lett; 2012 Mar; 511(2):116-9. PubMed ID: 22309794
[TBL] [Abstract][Full Text] [Related]
15. The effect of corticosterone on reactivity to spatial novelty is mediated by central mineralocorticosteroid receptors.
Oitzl MS; Fluttert M; de Kloet ER
Eur J Neurosci; 1994 Jul; 6(7):1072-9. PubMed ID: 7952288
[TBL] [Abstract][Full Text] [Related]
16. Potentiation of angiotensin II-induced drinking by glucocorticoids is a specific glucocorticoid type II receptor (GR)-mediated event.
Sumners C; Gault TR; Fregly MJ
Brain Res; 1991 Jun; 552(2):283-90. PubMed ID: 1913190
[TBL] [Abstract][Full Text] [Related]
17. Traumatic brain injury regulates adrenocorticosteroid receptor mRNA levels in rat hippocampus.
McCullers DL; Sullivan PG; Scheff SW; Herman JP
Brain Res; 2002 Aug; 947(1):41-9. PubMed ID: 12144851
[TBL] [Abstract][Full Text] [Related]
18. Antagonism of type II, but not type I glucocorticoid receptors results in elevated basal luteinizing hormone release in male rats.
Briski KP; Sylvester PW
Neuroendocrinology; 1994 Dec; 60(6):601-8. PubMed ID: 7700503
[TBL] [Abstract][Full Text] [Related]
19. Adrenocorticosteroid receptor blockade and excitotoxic challenge regulate adrenocorticosteroid receptor mRNA levels in hippocampus.
McCullers DL; Herman JP
J Neurosci Res; 2001 May; 64(3):277-83. PubMed ID: 11319772
[TBL] [Abstract][Full Text] [Related]
20. Brain mineralocorticoid receptor control of blood pressure and kidney function in normotensive rats.
Rahmouni K; Barthelmebs M; Grima M; Imbs JL; Wybren De Jong
Hypertension; 1999 May; 33(5):1201-6. PubMed ID: 10334812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
